A. E. EŞKAZAN, "Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?," LEUKEMIA , vol.34, no.12, pp.3426-3427, 2020
EŞKAZAN, A. E. 2020. Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?. LEUKEMIA , vol.34, no.12 , 3426-3427.
EŞKAZAN, A. E., (2020). Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?. LEUKEMIA , vol.34, no.12, 3426-3427.
EŞKAZAN, Ahmet. "Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?," LEUKEMIA , vol.34, no.12, 3426-3427, 2020
EŞKAZAN, Ahmet E. . "Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?." LEUKEMIA , vol.34, no.12, pp.3426-3427, 2020
EŞKAZAN, A. E. (2020) . "Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?." LEUKEMIA , vol.34, no.12, pp.3426-3427.
@article{article, author={Ahmet Emre EŞKAZAN}, title={Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?}, journal={LEUKEMIA}, year=2020, pages={3426-3427} }